LMP Capital and Income Fund offers a 9.7% yield, focusing on income generation through a diversified asset mix. See why SCD ...

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the green light for use by the NHS in England under a managed access scheme ...

In a landmark advancement for Indian healthcare, doctors at FMRI, Gurugram, have reported exceptional success in curing ...

We earn a commission for products purchased through some links in this article. ©2025 Hearst UK is the trading name of the National Magazine Company Ltd, 30 Panton ...